Literature DB >> 21172723

Anticoagulant and anti-platelet activity of polyphenolic-polysaccharide preparation isolated from the medicinal plant Erigeron canadensis L.

Izabela Pawlaczyk1, Leszek Czerchawski, Wiktor Kuliczkowski, Bożena Karolko, Witold Pilecki, Wojciech Witkiewicz, Roman Gancarz.   

Abstract

The polyphenolic-polysaccharide preparation from Erigeron canadensis L. was isolated by multi-step process, characterized by chromatographic and spectroscopic methods, and was subjected to anion-exchange chromatography. The whole preparation demonstrated in vivo anticoagulant activity, and the effect was neutralized by protamine sulfate. It had also anti-platelet activity, limited to the cyclooxygenase pathway, induced by arachidonic acid. The plant preparation was fractionated to receive the fraction of the highest anticoagulant activity - 7-9IU/mg of heparin standard, expressed in aPTT. The influences of the plant preparation as well as its the most active fraction on thrombin and factor Xa inactivation by antithrombin, and on thrombin inhibition by heparin cofactor II, were compared. The both tested plant preparations inhibited thrombin as well as factor Xa amidolytic activities in the presence of antithrombin, but much higher concentrations were required to obtain the same effects like for unfractionated heparin. The mechanisms of anticoagulant activity in the case of the plant preparation are based on interactions with heparin cofactor II, to inactivate thrombin. Chromatographic and spectroscopic methods revealed its macromolecular polyanionic non-sulfated polyphenolic-polysaccharide conjugate, with carboxylic groups. The polysaccharide part constituted 32% of the total mass and was homogenous, with molecular mass 38kDa, containing mainly hexuronic acids, and much smaller amounts of glucose, arabinose, galactose, as well as some traces of mannose, xylose and rhamnose. Polyphenolic part, with molecular mass >12.5kDa, was rich in hydroxylic rests as well as in carboxylic groups, free and esterified. The polyphenolic-polysaccharide preparation from E. canadensis may become a new source of anticoagulant compound potentially useful in anticoagulant and anti-platelet therapy.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172723     DOI: 10.1016/j.thromres.2010.11.031

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  12 in total

1.  Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.

Authors:  Rami A Al-Horani; Aiye Liang; Umesh R Desai
Journal:  J Med Chem       Date:  2011-08-12       Impact factor: 7.446

2.  Trifolium pallidum and Trifolium scabrum extracts in the protection of human plasma components.

Authors:  Joanna Kolodziejczyk-Czepas; Beata Olas; Joanna Malinowska; Barbara Wachowicz; Barbara Moniuszko-Szajwaj; Iwona Kowalska; Wieslaw Oleszek; Anna Stochmal
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

Review 3.  Natural Products for Antithrombosis.

Authors:  Cen Chen; Feng-Qing Yang; Qian Zhang; Feng-Qin Wang; Yuan-Jia Hu; Zhi-Ning Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

4.  Thrombin inhibitory activity of some polyphenolic compounds.

Authors:  M Bijak; R Ziewiecki; J Saluk; M Ponczek; I Pawlaczyk; H Krotkiewski; B Wachowicz; P Nowak
Journal:  Med Chem Res       Date:  2013-10-16       Impact factor: 1.965

5.  Anticoagulant Activity of Polyphenolic-Polysaccharides Isolated from Melastoma malabathricum L.

Authors:  Li Teng Khoo; Faridah Abas; Janna Ong Abdullah; Eusni Rahayu Mohd Tohit; Muhajir Hamid
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-20       Impact factor: 2.629

6.  Anti-inflammatory effect of methanol extract from Erigeron Canadensis L. may be involved with upregulation of heme oxygenase-1 expression and suppression of NFκB and MAPKs activation in macrophages.

Authors:  Jeehye Sung; Misun Sung; Younghwa Kim; Hyeonmi Ham; Heon-Sang Jeong; Junsoo Lee
Journal:  Nutr Res Pract       Date:  2014-05-15       Impact factor: 1.926

7.  Directional preparation of anticoagulant-active sulfated polysaccharides from Enteromorpha prolifera using artificial neural networks.

Authors:  Jiefen Cui; Yinping Li; Shixin Wang; Yongzhou Chi; Hueymin Hwang; Peng Wang
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

Review 8.  Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.

Authors:  Mohamed S Abdel-Bakky; Elham Amin; Mohamed G Ewees; Nesreen I Mahmoud; Hamdoon A Mohammed; Waleed M Altowayan; Ahmed A H Abdellatif
Journal:  Viruses       Date:  2022-01-24       Impact factor: 5.048

Review 9.  Current update on herbal sources of antithrombotic activity-a comprehensive review.

Authors:  Bhavani Subramani; P Sathiyarajeswaran
Journal:  Egypt J Intern Med       Date:  2022-03-07

Review 10.  Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Authors:  Ashis K Mukherjee; Dhruba J Chattopadhyay
Journal:  Phytother Res       Date:  2022-02-11       Impact factor: 6.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.